Perceptive LIFE Sciences Master FUND Ltd., Director at Cerevel Therapeutics Holdings, Inc. (CERE), bought 1,425,000 shares at $35.00 ($49.9M) on 2022-08-16, disclosed to the SEC on 2022-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |